このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs) (RDAD)

2017年9月14日 更新者：Linda Teri、University of Washington

From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services

The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.

調査の概要

状態

完了

条件

介入・治療

研究の種類

介入

入学 (実際)

510

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

  • アメリカ
    • Washington
      • Seattle、Washington、アメリカ、98195
        • University of Washington

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

65年歳以上 (高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

Care Recipients must

  • Have a diagnosis of dementia
  • Be 65 years of age or older
  • Currently exercise no more than 150 minutes a week and not regularly participate in a formal exercise program.

Caregivers must

  • Live in the community
  • Provide care to the care recipient with dementia

Exclusion Criteria:

Either Care-recipient or Caregiver must not

  • Plan to move to a long-term residential care setting within 6 months of enrollment.
  • Plan to move from the study geographic area within 4 months of enrollment.
  • Have a known terminal illness (with death anticipated within the next 12 months)
  • Have had a hospitalization for a psychiatric disorder in the 12 months prior to baseline
  • Be actively suicidal, hallucinating, or delusional
  • Be blind, deaf, or not ambulatory

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか？

デザインの詳細

  • 主な目的：処理
  • 割り当て：なし
  • 介入モデル：単一グループの割り当て
  • マスキング：なし（オープンラベル）

武器と介入

参加者グループ / アーム
介入・治療
他の：RDAD
Exercise training for caregiver and care recipient. Behavior modification training for caregiver.
行動：RDAD
Exercise training for caregiver and care recipient. Behavioral modification training for caregiver.

この研究は何を測定していますか？

主要な結果の測定

結果測定
メジャーの説明
時間枠
Minutes of exercise per week
時間枠：Change from baseline in number of minutes of exercise each week during treatment phase of study, weeks 7-12
Caregivers will track the number of minutes per week the care recipients engage in exercise recommended by the coach.
Change from baseline in number of minutes of exercise each week during treatment phase of study, weeks 7-12
Restricted Activity Days
時間枠：Baseline
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Baseline
Restricted Activity Days
時間枠：Change from Baseline to Pre-Treatment (6 weeks)
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Change from Baseline to Pre-Treatment (6 weeks)
Restricted Activity Days
時間枠：Change from Baseline to Post- Treatment 1 (13 weeks)
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Change from Baseline to Post- Treatment 1 (13 weeks)
Restricted Activity Days
時間枠：Change from Baseline to Post-Treatment 2 (30 weeks)
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Change from Baseline to Post-Treatment 2 (30 weeks)
Restricted Days of Activity
時間枠：Change from Baseline to 13 Month Follow-Up
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Change from Baseline to 13 Month Follow-Up
Independence/Residential Status
時間枠：Change from Baseline to 13 Month Follow-Up
All participants will be in independent living situations at baseline. Any move from independent living to a care facility will be documented throughout the 13 month study.
Change from Baseline to 13 Month Follow-Up

二次結果の測定

結果測定
メジャーの説明
時間枠
Revised Memory and Behavior Problem Checklist (RMBPC)
時間枠：Baseline
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Baseline
Revised Memory and Behavior Problem Checklist (RMBPC)
時間枠：Change from Baseline to Pre-Treatment (6 weeks)
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Change from Baseline to Pre-Treatment (6 weeks)
Revised Memory and Behavior Problem Checklist (RMBPC)
時間枠：Change from Baseline to Post-Treatment 1 (13 weeks)
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Change from Baseline to Post-Treatment 1 (13 weeks)
Revised Memory and Behavior Problem Checklist (RMBPC)
時間枠：Change from Baseline to Post-Treatment 2 (30 weeks)
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Change from Baseline to Post-Treatment 2 (30 weeks)
Revised Memory and Behavior Problem Checklist (RMBPC)
時間枠：Change from Baseline to 13 Month Follow-Up
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Change from Baseline to 13 Month Follow-Up
Quality of Life-AD
時間枠：Baseline
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Baseline
Quality of Life-AD
時間枠：Change from Baseline to Pre-Treatment (6 weeks)
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Change from Baseline to Pre-Treatment (6 weeks)
Quality of Life-AD
時間枠：Change from Baseline to Post-Treatment 1 (13 weeks)
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Change from Baseline to Post-Treatment 1 (13 weeks)
Quality of Life-AD
時間枠：Change from Baseline to Post-Treatment 2 (30 weeks)
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Change from Baseline to Post-Treatment 2 (30 weeks)
Quality of Life-AD
時間枠：Change from Baseline to 13 Month Follow-Up
This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.
Change from Baseline to 13 Month Follow-Up
CES-D
時間枠：Baseline
This 20-item scale that assesses depression in caregivers.
Baseline
CES-D
時間枠：Change from Baseline to Pre-Treatment (6 weeks)
A 20-item scale that assesses depression in caregivers.
Change from Baseline to Pre-Treatment (6 weeks)
CES-D
時間枠：Change from Baseline to Post-Treatment 1 (13 weeks)
A 20-item scale that assesses depression in caregivers.
Change from Baseline to Post-Treatment 1 (13 weeks)
CES-D
時間枠：Change from Baseline to Post-Treatment 2 (30 weeks)
A 20-item scale that assesses depression in caregivers.
Change from Baseline to Post-Treatment 2 (30 weeks)
CES-D
時間枠：Change from Baseline to 13 Month Follow-Up
A 20-item scale that assesses depression in caregivers.
Change from Baseline to 13 Month Follow-Up

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

University of Washington

捜査官

  • 主任研究者：Linda Teri, Ph.D.、University of Washington

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2012年11月1日

一次修了 (実際)

2017年6月1日

研究の完了 (実際)

2017年6月1日

試験登録日

最初に提出

2012年10月9日

QC基準を満たした最初の提出物

2012年10月15日

最初の投稿 (見積もり)

2012年10月16日

学習記録の更新

投稿された最後の更新 (実際)

2017年9月15日

QC基準を満たした最後の更新が送信されました

2017年9月14日

最終確認日

2017年9月1日

詳しくは

本研究に関する用語

キーワード

追加の関連 MeSH 用語

その他の研究ID番号

  • 41906

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する